Your browser doesn't support javascript.
loading
Activity of Imipenem-Relebactam against Carbapenem-Resistant Escherichia coli Isolates from the United States in Relation to Clonal Background, Resistance Genes, Coresistance, and Region.
Johnston, Brian D; Thuras, Paul; Porter, Stephen B; Anacker, Melissa; VonBank, Brittany; Vagnone, Paula Snippes; Witwer, Medora; Castanheira, Mariana; Johnson, James R.
Affiliation
  • Johnston BD; Minneapolis VA Health Care System, Minneapolis, Minnesota, USA.
  • Thuras P; University of Minnesota, Minneapolis, Minnesota, USA.
  • Porter SB; Minneapolis VA Health Care System, Minneapolis, Minnesota, USA.
  • Anacker M; University of Minnesota, Minneapolis, Minnesota, USA.
  • VonBank B; Minneapolis VA Health Care System, Minneapolis, Minnesota, USA.
  • Vagnone PS; Minnesota Department of Health, St. Paul, Minnesota, USA.
  • Witwer M; Minnesota Department of Health, St. Paul, Minnesota, USA.
  • Castanheira M; Minnesota Department of Health, St. Paul, Minnesota, USA.
  • Johnson JR; Minnesota Department of Health, St. Paul, Minnesota, USA.
Article in En | MEDLINE | ID: mdl-32152073

Full text: 1 Database: MEDLINE Main subject: Imipenem / Drug Resistance, Bacterial / Escherichia coli / Azabicyclo Compounds / Beta-Lactamase Inhibitors / Anti-Bacterial Agents Type of study: Risk_factors_studies Limits: Humans Country/Region as subject: America do norte Language: En Year: 2020 Type: Article

Full text: 1 Database: MEDLINE Main subject: Imipenem / Drug Resistance, Bacterial / Escherichia coli / Azabicyclo Compounds / Beta-Lactamase Inhibitors / Anti-Bacterial Agents Type of study: Risk_factors_studies Limits: Humans Country/Region as subject: America do norte Language: En Year: 2020 Type: Article